A Systematic Review of the Efficacy and Safety of a Purified, Pasteurized C1 Inhibitor Concentrate for the Treatment of Patients With Type I or II Hereditary Angioedema

Allergy, Asthma and Clinical Immunology - United Kingdom
doi 10.1186/1710-1492-6-s1-p32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search